Literature DB >> 17357058

Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children.

Qibo Zhang1, Linda Bagrade, Jolanta Bernatoniene, Ed Clarke, James C Paton, Tim J Mitchell, Desmond A Nunez, Adam Finn.   

Abstract

BACKGROUND: Recent studies in mice have suggested that T cell immunity may be protective against pneumococcal infection.
METHODS: CD4 T cell proliferative responses to the pneumococcal proteins pneumolysin (Ply), Ply toxoid (F433), and choline-binding protein A were investigated in peripheral blood mononuclear cells (PBMCs) and adenoidal mononuclear cells (MNCs) obtained from children undergoing adenoidectomy.
RESULTS: Ply and F433 induce significant proliferation of CD4 T cells in both PBMCs and adenoidal MNCs, and both memory and naive phenotypes of CD4 T cells proliferated after stimulation. In PBMCs, CD4 T cell proliferation induced by Ply and F433, which was associated with increased production of interferon (IFN)- gamma and tumor necrosis factor (TNF)- alpha , was significantly lower in children who were culture positive for pneumococcus than in those who were culture negative for pneumococcus (P<.05). Between groups, no such difference was observed in adenoidal MNC CD4 T cell proliferation, which was associated with production of IFN- gamma and interleukin (IL)-10. The CD4 T cell proliferation induced by Ply and F433 was inhibited by antibodies to Toll-like receptor 4.
CONCLUSION: These data suggest that Ply induces CD4 T cell proliferative responses with production of IFN- gamma and TNF- alpha in PBMCs or of IFN- gamma and IL-10 in adenoidal MNCs, which may be important in modulating pneumococcal carriage in children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17357058     DOI: 10.1086/512617

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

Review 1.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

2.  MicroRNA-155 is required for clearance of Streptococcus pneumoniae from the nasopharynx.

Authors:  Chris P Verschoor; Michael G Dorrington; Kyle E Novakowski; Julie Kaiser; Katherine Radford; Parameswaran Nair; Varun Anipindi; Charu Kaushic; Michael G Surette; Dawn M E Bowdish
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 3.  Cellular immune response in young children accounts for recurrent acute otitis media.

Authors:  Sharad K Sharma; Michael E Pichichero
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

4.  Activation-dependent modulation of Streptococcus pneumoniae-mediated death in human lymphocytes.

Authors:  Kristina M Grayson; Lance K Blevins; Melissa B Oliver; David A Ornelles; W Edward Swords; Martha A Alexander-Miller
Journal:  Pathog Dis       Date:  2017-03-01       Impact factor: 3.166

5.  Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation.

Authors:  Sharad K Sharma; Janet R Casey; Michael E Pichichero
Journal:  J Infect Dis       Date:  2012-03-01       Impact factor: 5.226

6.  Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country.

Authors:  Anna Lundgren; Taufiqur R Bhuiyan; Daniel Novak; Joanna Kaim; Adi Reske; Ying-Jie Lu; Firdausi Qadri; Richard Malley
Journal:  Vaccine       Date:  2012-04-12       Impact factor: 3.641

7.  Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition.

Authors:  Sharad K Sharma; Janet R Casey; Michael E Pichichero
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

Review 8.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

9.  Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.

Authors:  Alan Basset; Claudette M Thompson; Susan K Hollingshead; David E Briles; Edwin W Ades; Marc Lipsitch; Richard Malley
Journal:  Infect Immun       Date:  2007-08-13       Impact factor: 3.441

Review 10.  Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development.

Authors:  Richard Malley
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.